Rapid Sterility
Rapid sterility is an alternative microbiological test method to the US Pharmacopeia (USP) <71>, Ph. Eur. 2.6.1, and JP 4.06 sterility tests that allows for shorter incubation periods and faster results. Alcami utilizes the Milliflex® Rapid System for the rapid sterility test, which uses adenosine triphosphate (ATP) bioluminescence for detection of microorganisms after five days.
-1.jpg)
Qualification and Certification Support Benefits of Rapid Sterility
-
Faster release of drug product, especially valuable in the case of market shortage products
-
Corrective action can be implemented sooner if the product does not meet specification
-
Scientifically demonstrated to have comparable recovery to the harmonized USP <71> reference method
-
Like the reference method, microorganisms detected using the Milliflex® Rapid System can later be identified to the species level
-
Reduced observation bias
Limitations of Traditional Sterility Testing
-
Lengthy incubation time results in increased holding/inventory costs
-
Requires multiple manual reads based on analyst observation
-
Longer time to product release, delaying time to market
-
Not ideal for products with short shelf lives and beyond use dates (BUDs)
-
Limits facility throughput
Alcami’s Milliflex® Rapid Sterility System is an ideal rapid method that has proven comparability to USP <71>. Alcami can meet your tight timelines and provide an alternative to rush sterility tests.
Ready to Get Started?
Complete this form to connect to a member of the Alcami team.